Siemens Healthineers Mar 19 2026 Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for  1 . Every year, there are nearly 10 million new cases of dementia diagnosed worldwide 2 . Alzheimer's disease is the most common, contributing to 60-70 % of cases, though it affects many more people over time as these